Candel Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $676 | 138 | 4.90 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas